{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:18:11Z","timestamp":1783041491963,"version":"3.54.6"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.yebeh.2017.05.022","type":"journal-article","created":{"date-parts":[[2017,6,14]],"date-time":"2017-06-14T16:15:17Z","timestamp":1497456917000},"page":"71-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Co-morbidity and clinically significant interactions between antiepileptic drugs and other drugs in elderly patients with newly diagnosed epilepsy"],"prefix":"10.1016","volume":"73","author":[{"given":"Emmi","family":"Bruun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri J.","family":"Virta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reetta","family":"K\u00e4lvi\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapani","family":"Ker\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.yebeh.2017.05.022_bb0005","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1528-1157.1998.tb01294.x","article-title":"Antiepileptic drug use in nursing home residents: effect of age, gender, and comedication on patterns of use","volume":"39","author":"Lackner","year":"1998","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2017.05.022_bb0010","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11940-009-0029-1","article-title":"Antiepileptic drugs and other medications: what interactions may arise?","volume":"11","author":"Mani","year":"2009","journal-title":"Curr Treat Options Neurol"},{"issue":"3","key":"10.1016\/j.yebeh.2017.05.022_bb0015","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1532-5415.2010.02732.x","article-title":"Choice of initial antiepileptic drug for older veterans: possible pharmacokinetic drug interactions with existing medications","volume":"58","author":"Pugh","year":"2010","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"10.1016\/j.yebeh.2017.05.022_bb0020","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.1528-1167.2012.03528.x","article-title":"The somatic comorbidity of epilepsy: a weighty but often unrecognized burden","volume":"53","author":"Gaitatzis","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.05.022_bb0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.seizure.2015.06.016","article-title":"Choice of the first anti-epileptic drug in elderly patients with newly diagnosed epilepsy: a Finnish retrospective study","volume":"31","author":"Bruun","year":"2015","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.yebeh.2017.05.022_bb0030","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0920-1211(02)00031-1","article-title":"Differences in the use of health services among people with and without epilepsy in the United Kingdom: socio-economic and disease-specific determinants","volume":"50","author":"Gaitatzis","year":"2002","journal-title":"Epilepsy Res"},{"issue":"12","key":"10.1016\/j.yebeh.2017.05.022_bb0035","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.0013-9580.2004.17504.x","article-title":"The epidemiology of the comorbidity of epilepsy in the general population","volume":"45","author":"Gaitatzis","year":"2004","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.yebeh.2017.05.022_bb0040","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1111\/j.1528-1167.2005.00344.x","article-title":"Somatic comorbidity of epilepsy in the general population in Canada","volume":"46","author":"T\u00e9llez-Zenteno","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2017.05.022_bb0045","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.eplepsyres.2013.12.002","article-title":"Epilepsy beyond seizure: a population-based study of comorbidities","volume":"108","author":"Selassie","year":"2014","journal-title":"Epilepsy Res"},{"issue":"5","key":"10.1016\/j.yebeh.2017.05.022_bb0050","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/ane.12218","article-title":"Epilepsy in the elderly: comparing clinical characteristics with younger patients","volume":"129","author":"Stefan","year":"2014","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2017.05.022_bb0055","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.eplepsyres.2006.06.018","article-title":"Incidence of epilepsy in a racially diverse, community-dwelling, elderly cohort: results from the Einstein aging study","volume":"71","author":"Hussain","year":"2006","journal-title":"Epilepsy Res"},{"issue":"2","key":"10.1016\/j.yebeh.2017.05.022_bb0060","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1532-5415.2008.02124.x","article-title":"New-onset epilepsy risk factors in older veterans","volume":"57","author":"Pugh","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.yebeh.2017.05.022_bb0065","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/ageing\/afv061","article-title":"Incidence of stroke and seizure in Alzheimer's disease dementia","volume":"44","author":"Cook","year":"2015","journal-title":"Age Ageing"},{"key":"10.1016\/j.yebeh.2017.05.022_bb0070","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.seizure.2012.05.015","article-title":"Comorbid and underlying diseases \u2013 major determinants of excess mortality in epilepsy","volume":"21","author":"Aurlien","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2017.05.022_bb0075","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.yebeh.2014.08.131","article-title":"Diagnoses, procedures, drug utilization, comorbidities, and cost of health care for people with epilepsy in 2012","volume":"41","author":"Wilner","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2017.05.022_bb0080","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1684\/epd.2014.0714","article-title":"Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs","volume":"16","author":"Zaccara","year":"2014","journal-title":"Epileptic Disord"},{"issue":"4","key":"10.1016\/j.yebeh.2017.05.022_bb0085","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1528-1157.2002.13001.x","article-title":"The importance of drug interactions in epilepsy therapy","volume":"43","author":"Patsalos","year":"2002","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2017.05.022_bb0090","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/00002512-200320020-00005","article-title":"Drug treatment of epilepsy in elderly people: focus on valproic acid","volume":"20","author":"Stephen","year":"2003","journal-title":"Drugs Aging"},{"issue":"5","key":"10.1016\/j.yebeh.2017.05.022_bb0095","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/01.wnl.0000341789.77291.8d","article-title":"Assessment of potential drug interactions in patients with epilepsy: impact of age and sex","volume":"72","author":"Gidal","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2017.05.022_bb0100","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eplepsyres.2016.08.023","article-title":"Outcome of initial antiepileptic drug treatment in elderly patients with newly diagnosed epilepsy","volume":"127","author":"Bruun","year":"2016","journal-title":"Epilepsy Res"},{"issue":"6","key":"10.1016\/j.yebeh.2017.05.022_bb0105","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00228-008-0612-5","article-title":"SFINX \u2013 a drug\u2013drug interaction database designed for clinical decision support systems","volume":"65","author":"B\u00f6ttiger","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.yebeh.2017.05.022_bb0110","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijmedinf.2015.01.013","article-title":"Evaluation of usage patterns and user perception of the drug\u2013drug interaction database SFINX","volume":"84","author":"Andersson","year":"2015","journal-title":"Int J Med Inform"},{"key":"10.1016\/j.yebeh.2017.05.022_bb0115","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.seizure.2013.04.009","article-title":"Risk factors of recurrent seizure, co-morbidities, and mortality in new onset seizure[s] in [the] elderly","volume":"22","author":"Phabphal","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2017.05.022_bb0120","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2165\/00002512-200926060-00006","article-title":"Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis","volume":"26","author":"Jyrkk\u00e4","year":"2009","journal-title":"Drugs Aging"},{"key":"10.1016\/j.yebeh.2017.05.022_bb0125","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0140-6736(88)90124-9","article-title":"Reduced felodipine bioavailability in patients taking anticonvulsants","volume":"2","author":"Capewell","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2017.05.022_bb0130","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/cpt1971123539","article-title":"Carbamazepine-induced acceleration of diphenylhydantoin and warfarin metabolism in man","volume":"12","author":"Hansen","year":"1971","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.yebeh.2017.05.022_bb0135","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/00007691-200008000-00019","article-title":"Plasma concentrations of risperidone and 9-hydroxyrisperidone: effect of comedication with carbamazepine or valproate","volume":"22","author":"Spina","year":"2000","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.yebeh.2017.05.022_bb0140","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/pgmj.75.884.359","article-title":"Efficacy of statin therapy: possible effect of phenytoin","volume":"75","author":"Murphy","year":"1999","journal-title":"Postgrad Med"},{"key":"10.1016\/j.yebeh.2017.05.022_bb0145","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00228-003-0700-5","article-title":"Carbamazepine markedly reduces serum concentrations of simvastatin and simvastatin acid","volume":"59","author":"Ucar","year":"2004","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2017.05.022_bb0150","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/pds.3287","article-title":"Statin medication in patients treated with antiepileptic drugs in Norway","volume":"21","author":"Gedde-Dahl","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.yebeh.2017.05.022_bb0155","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.yebeh.2014.03.008","article-title":"Use of antiepileptic drugs and lipid-lowering agents in the United States","volume":"34","author":"Mintzer","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2017.05.022_bb0160","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1600-0404.2010.01372.x","article-title":"Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine","volume":"190","author":"Svalheim","year":"2010","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1016\/j.yebeh.2017.05.022_bb0165","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2165\/00002018-200730100-00009","article-title":"The relationship between number of drugs and potential drug\u2013drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register","volume":"30","author":"Johnell","year":"2007","journal-title":"Drug Saf"},{"key":"10.1016\/j.yebeh.2017.05.022_bb0170","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00228-012-1338-y","article-title":"Impact of the drug\u2013drug interaction database SFINX on prevalence of potentially serious drug\u2013drug interactions in primary health care","volume":"69","author":"Andersson","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2017.05.022_bb0175","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.eplepsyres.2015.11.009","article-title":"Elderly nursing home epilepsy assessment \u2013 Pavia Study Group. Antiepileptic drug use and epileptic seizures in nursing home residents in the province of Pavia, Italy: a reappraisal 12 years after a first survey","volume":"119","author":"Galimberti","year":"2016","journal-title":"Epilepsy Res"},{"issue":"6","key":"10.1016\/j.yebeh.2017.05.022_bb0180","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1212\/01.wnl.0000252941.50833.4a","article-title":"Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy","volume":"68","author":"Brodie","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2017.05.022_bb0185","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1528-1167.2007.01128.x","article-title":"An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly","volume":"48","author":"Saetre","year":"2007","journal-title":"Epilepsia"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505017301026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505017301026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T05:25:27Z","timestamp":1602307527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505017301026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":37,"alternative-id":["S1525505017301026"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2017.05.022","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-morbidity and clinically significant interactions between antiepileptic drugs and other drugs in elderly patients with newly diagnosed epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2017.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}